• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. SINGLE USE ASPIRATION NEEDLE NA-U200H

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. SINGLE USE ASPIRATION NEEDLE NA-U200H Back to Search Results
Model Number NA-U200H-8019
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Peritonitis (2252)
Date of Event 01/31/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
E1-facility name: (b)(6).The reports of the following patient identifiers are linked: (b)(6).The investigation is ongoing.A supplemental report will be submitted when the investigation is completed or if additional information becomes available.
 
Event or Problem Description
Olympus reviewed the following literature titled "emergent treatment using balloon-assisted ercp versus eus-guided drainage for acute cholangitis in patients with surgically altered anatomy.¿ background: no studies have compared balloon-assisted endoscope-guided endoscopic retrograde cholangiopancreatography (bae-ercp) and endoscopic ultrasonography-guided biliary drainage (eus-bd) for emergent treatment of acute cholangitis (ac) in patients with upper gastrointestinal surgically altered anatomy (saa).Methods: this study retrospectively evaluated consecutive patients who underwent emergent bae-ercp or eus-bd for ac with saa between january 2020 and march 2024.Technical success, clinical success, procedure time, and adverse events (aes) were compared between the two groups.Results: this study included 23 patients in the bae-ercp group and 14 patients in the eus-bd group.Technical success and clinical success rates did not significantly differ between the two groups (88% vs.100%, p = 0.51 and 95% vs.93%, p = 0.66).Similarly, the rate of aes was comparable between the two groups (4% vs.14%, p = 0.54).The median procedure time was significantly shorter in the eus-bd group than in the bae-ercp group (32.5 [interquartile range; iqr, 28.8¿52.5] minutes vs.70.0 [iqr, 60.0¿90.0] minutes, p < 0.01).In cases with grade 2 or 3 cholangitis, the rates of technical success, clinical success, and aes did not significantly differ between the two groups.However, the median procedure time was significantly shorter in the eus-bd group than in the bae-ercp group (32.5 [iqr, 28.8¿52.5] minutes vs.70 [iqr, 56.3¿90.0] minutes, p < 0.01).Conclusion: while both bae-ercp and eus-bd can be performed safely and effectively in patients with ac and saa, the procedure time is significantly shorter with eus-bd than with bae-ercp.Type of adverse events/number of patients peritonitis (2 patients).
 
Additional Manufacturer Narrative
This supplemental report is being submitted to provide the results of the legal manufacturer's final investigation.Updated fields: b5, h6.The device was not returned for evaluation; therefore, a definitive root cause could not be determined.The most probable cause was not established; the investigation findings do not lead to a clear conclusion about the cause of the reported adverse event.Olympus will continue to monitor field performance for this device.
 
Event or Problem Description
Additional information received from the author that confirmed no device malfunctioned, and no device caused or contributed to the adverse events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINGLE USE ASPIRATION NEEDLE NA-U200H
Common Device Name
SINGLE USE ASPIRATION NEEDLE
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA   036-0357
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key21576718
Report Number9614641-2025-00295
Device Sequence Number15521774
Product Code FCG
UDI-Device Identifier04953170380402
UDI-Public04953170380402
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K180449
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Study,Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberNA-U200H-8019
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/12/2025
Supplement Date Received by Manufacturer03/13/2025
Initial Report FDA Received Date03/11/2025
Supplement Report FDA Received Date04/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GF-UCT260 GASTROVIDEOSCOPE
Patient SexUnknown
-
-